Suchergebnisse - "Liu, Yueping"

PubPharm (279)

11

Concordance of assessments of four PD-L1 immunohistochemical assays in esophageal squamous cell carcinoma (ESCC)

enthalten in: Journal of cancer research and clinical oncology | 2024

von Wang, X. | He, J. | Li, J. | +7

12

Novel Association of RAD54L Mutation with Müllerian Clear Cell Carcinoma of the Male Urethra : New Insights Regarding the Molecular Mechanisms of a Rare Tumour

enthalten in: Current cancer drug targets | 2024

von Deng, H. | Ding, Y. | Yin, D. | +4

13

Clinicopathological features and prognostic analysis of HER2 low and fibrotic focus in HER2-negative breast cancer

enthalten in: Breast cancer research and treatment | 2024

von Yue, M. | Wu, S. | Liu, C. | +5

14

Impact of HER2-low status for patients with early-stage breast cancer and non-pCR after neoadjuvant chemotherapy : a National Cancer Database Analysis

enthalten in: Breast cancer research and treatment | 2024

von Li, H. | Plichta, J. | Li, K. | +11

15

Proficiency testing of diagnosis in histopathology and immunohistochemistry of breast pathology in China : results from a pilot work of National Single Disease Quality Control Program for breast cancer

enthalten in: BMC cancer | 2024

von Xue, X. | Guo, L. | Guo, C. | +15

16

Proficiency testing of diagnosis in histopathology and immunohistochemistry of breast pathology in China: results from a pilot work of National Single Disease Quality Control Program for breast cancer

enthalten in: BMC cancer | 2024

von Xue, X. | Guo, L. | Guo, C. | +15

17

Adaptive ultra‐hypofractionated whole‐pelvic radiotherapy in high‐risk and very high‐risk prostate cancer on 1.5‐Tesla MR‐Linac : Estimated delivered dose and early toxicity results

enthalten in: Chronic Diseases and Translational Medicine | 2024

von Gao, L. | Wei, R. | Qin, S. | +14

18

Image processing method and device, equipment, storage medium and program product

enthalten in: Europäisches Patentamt | 2023

von LIAO JUN | YAO JIANHUA | LIU YUEPING | +1

19

An Analysis of Clinical and Pathologic Features, RecurIndex Genomic Profiles, and Survival Outcomes in HER2-Low Breast Cancer

enthalten in: The oncologist | 2023

von Hui, T. | Li, S. | Wang, H. | +9

20

The new idea of cancer immunotherapy: the expression of PD-L1 may reveal the immunological mechanism of resistance of EGFR-TKIs

enthalten in: ResearchSquare.com | 2023

von Jia, Y. | Li, S. | Wang, X. | +7